Cataract in the adult eye preferred practice pattern®
Preferred Practice Pattern® guidelines are developed by the Academy's H. Dunbar Hoskins
Jr., MD Center for Quality Eye Care without any external financial support. Authors and …
Jr., MD Center for Quality Eye Care without any external financial support. Authors and …
Complications of intravitreal injections
KM Sampat, SJ Garg - Current opinion in ophthalmology, 2010 - journals.lww.com
Intravitreal injections play a critical role in daily ophthalmic practice. The overall risk of
endophthalmitis and retinal detachment appears to be low and most of the commonly used …
endophthalmitis and retinal detachment appears to be low and most of the commonly used …
Cataract in the Adult Eye Preferred Practice Pattern®
KM Miller, TA Oetting, JP Tweeten, K Carter, BS Lee… - Ophthalmology, 2022 - Elsevier
Evidence-based update of the Cataract in the Adult Eye Preferred Practice Pattern®(PPP)
guidelines, describing the prevalence, risk factors, and natural history of cataract …
guidelines, describing the prevalence, risk factors, and natural history of cataract …
Intravitreal injection of therapeutic agents
GA Peyman, EM Lad, DM Moshfeghi - Retina, 2009 - journals.lww.com
Background: Intravitreal injection (IVI) with administration of various pharmacological agents
is a mainstay of treatment in ophthalmology for endopthalmitis, viral retinitis, age-related …
is a mainstay of treatment in ophthalmology for endopthalmitis, viral retinitis, age-related …
Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study
RA Costa, R Jorge, D Calucci, JR LUIZ A MELO… - Retina, 2007 - journals.lww.com
Purpose: To evaluate the safety, visual acuity changes, and morphologic effects associated
with intravitreal bevacizumab injections for the management of macular edema due to …
with intravitreal bevacizumab injections for the management of macular edema due to …
Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration
EM Becerra, F Morescalchi, F Gandolfo… - Current drug …, 2011 - ingentaconnect.com
Triamcinolone acetonide (TA) is one of the first pharmacologic compounds evaluated for the
treatment of choroidal neovascularization (CNV) secondary to age-related macular …
treatment of choroidal neovascularization (CNV) secondary to age-related macular …
Next generation therapeutics for retinal neurodegenerative diseases
MB Appell, J Pejavar, A Pasupathy… - Journal of Controlled …, 2024 - Elsevier
Neurodegenerative diseases affecting the visual system encompass glaucoma, macular
degeneration, retinopathies, and inherited genetic disorders such as retinitis pigmentosa …
degeneration, retinopathies, and inherited genetic disorders such as retinitis pigmentosa …
Cataract progression after primary pars plana vitrectomy for uncomplicated rhegmatogenous retinal detachments in young adults
Background Scleral buckling is typically implemented to repair rhegmatogenous retinal
detachments (RRD) in young patients. Therefore, there is limited data on post-pars plana …
detachments (RRD) in young patients. Therefore, there is limited data on post-pars plana …
The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane
Purpose: To compare the long-term anatomical and visual outcomes of patients with
idiopathic epiretinal membrane (ERM) removed by vitrectomy and membrane peeling with …
idiopathic epiretinal membrane (ERM) removed by vitrectomy and membrane peeling with …
Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
Purpose: To present the functional and anatomic changes after intravitreal bevacizumab in
eyes with macular edema (ME) due to branch retinal vein occlusion (BRVO). Design: The …
eyes with macular edema (ME) due to branch retinal vein occlusion (BRVO). Design: The …